SBRT May Beat Brachytherapy in Prostate Cancer

Published Date: 27 Feb 2026

In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.

Read Full News

Latest News

When in Breast Cancer Treatment Are CDK4/6 Inhibitors Best?

Researchers examined whether CDK4/6 inhibitors lead to better overall survival when used as first- or second-line treatment.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

Patients with breast cancer living in states with expanded Medicaid eligibility, have seen survival gains, raising more concerns about the impact of recent changes to the program.

FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC

The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.

Cancer and HIV Vaccines Enter the Therapeutic Era

Therapeutic vaccines are advancing in oncology and HIV, with the aim of retraining immune responses to target tumors and persistent viral reservoirs with precision.

Which Salvage Therapy Is Best for Recurrent Prostate Cancer?

Ten-year survival data support salvage focal therapy as an option for patients with localized recurrence after prostate cancer radiotherapy.

Home Screening Appeals to Women Facing Healthcare Barriers

Researchers asked more than 2000 women if they preferred at-home vaginal self-sampling over clinic-based testing to screen for cervical cancer.

Todays Updates

Treating Depression: Crucial for Recovery From Fibromyalgia

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

The Boom in ADHD Coaching Has Few Rules

Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.

Todays Updates

Treating Depression: Crucial for Recovery From Fibromyalgia

In patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.

The Boom in ADHD Coaching Has Few Rules

Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.

Latest News

Researchers examined whether CDK4/6 inhibitors lead to better overall survival when used as first- or second-line treatment.

Patients with breast cancer living in states with expanded Medicaid eligibility, have seen survival gains, raising more concerns about the impact of recent changes to the program.

The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.

Therapeutic vaccines are advancing in oncology and HIV, with the aim of retraining immune responses to target tumors and persistent viral reservoirs with precision.

Ten-year survival data support salvage focal therapy as an option for patients with localized recurrence after prostate cancer radiotherapy.

Researchers asked more than 2000 women if they preferred at-home vaginal self-sampling over clinic-based testing to screen for cervical cancer.

News All Time

US CDC Vaccine Panel to Meet in March After February Session Scrapped

The U.S. Centers for Disease Control and Prevention's vaccine advisory committee is set to meet on March ⁠18 to 19, an update on the agency's website showed on Tuesday,...

Exclusive-South Carolina Seeks Non-CDC Reinforcements to Contain Growing Measles Outbreak

A dozen public health experts are arriving in South Carolina to help the state contain the largest U.S. measles outbreak in more than 30 years, but they're not coming from...

BMI Shapes Oxytocin Needs in Labor Induction

Individuals receiving maximum oxytocin doses have elevated risk for cesarean delivery and postpartum hemorrhage, but the risks are attenuated in those with elevated BMI.

Mobile Telemedicine Boosts Rural Access to HCV Treatment

Among rural people with chronic HCV infection and a history of injection drug use, a mobile telemedicine-based intervention vs enhanced usual care improves treatment initiation and cure rates.

Long-Acting HIV Drug Switch Shows No Major Metabolic Impact

In patients with HIV infection, a switch to long acting cabotegravir plus rilpivirine shows no clinically meaningful changes in body composition or adverse metabolic effects over 48 weeks.

Zimbabwe Ends $367 Million Health Funding Talks With US

Zimbabwe has pulled out of talks on a $367 million bilateral health agreement with the US due to concerns over sharing sensitive health data in return for financial support.

Hospitals Face Measles Challenge: Few Doctors Have Seen It

As the US hospitals face an increasing risk of encountering measles, healthcare workers face an unusual barrier: Many don’t know what it looks like.

Blood Test Predicts Timing of Alzheimer’s Onset

Plasma p-tau217 levels predict the timing of Alzheimer’s onset in cognitively unimpaired adults in the research that could potentially guide research and preventive trials.

MDMA Analogue Shows Rapid, Durable Benefit in PTSD

A novel, non-hallucinogenic, experimental drug shows statistically significant, rapid, and durable improvement in PTSD symptom severity in a phase 2 trial.

Higher Genetic Risk for IBD Linked to Disease Severity

Higher genetic risk for inflammatory bowel disease is linked to more severe disease and increased risks for hospital stays and earlier need for advanced treatments.

Can Antidepressants Boost Poststroke Dysphagia Recovery?

Antidepressant therapy may independently improve recovery from dysphagia after acute ischemic stroke through multiple potential mechanisms, new data show.

Better Support Tied to Reduced Hospital Use in Older Adults

Stable or improved financial conditions and social support are linked to fewer hospital admissions among older adults with different levels of frailty.

FDA Grants Full Approval to Encorafenib in Metastatic CRC

Traditional approval of encorafenib plus cetuximab and fluorouracil-based chemotherapy for patients with BRAF-mutated metastatic colorectal cancer follows accelerated approval 2 years ago.

Democratic State AGs Announce Lawsuit Against Trump Administration Over US Vaccine Policy

Two Democratic state attorneys general announced a multistate lawsuit against the Trump administration on Tuesday ⁠over recent changes to the federal government's childhood...

Recommended News For You

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery

Studies show that treatment for non-Hodgkin's lymphoma is also focused on the lymphoma.

As pesticides and wildfires rise, kids with cancer need resources

Radiation therapy can promote amphiregulin, which increases growth of metastases

Nasal therapeutic HPV vaccine could prevent cervical cancer

Omicron Infections Are Usually Cleared Up in Immunocompromised Patients.

To automate the biopharmaceutical facilities of Reliance Life Sciences, ABB India has won the contract.

Recommended Articles For You

Unleashing the Inner Predator: Reprogramming Macrophages to Conquer Cancer Immunotherapy 

Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders 

The Power of White Blood Cells: How They Help Keep Us Healthy 

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

After HSCT, a longer course of letermovir prophylaxis decreased the risk of cytomegalovirus infection.

2.

Children with the "Failure to Launch" Syndrome in Adulthood Have New Hope.

3.

Analysis of projected cancer rates in Canada by 2024.

4.

Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia

5.

Do I qualify for a cancer clinical trial?

1.

Know About Lymphangioma: Symptoms, Causes, and Treatments

2.

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes

3.

Hematologic Cytomorphology: From Microscopy to Molecular Diagnostics

4.

Exploring the Impact of Adrenal Myelolipoma on the Human Body

5.

Navigating the Evolving Landscape of Oncology Clinical Trials in the Era of Precision Medicine

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

Dacomitinib Case Presentation: Baseline Treatment and Current Status

3.

CNS Clarity from Day One: Rethinking Early Diagnostic Strategies in ALK+NSCLC

4.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot